As we can see, the NRF2/KEAP1/ARE pathway is a key and complex structure involved in DKD pathophysiology, with a major role in decreasing OS (Figure 1) and, therefore, it raises particular therapeutic opportunities in the management of DKD. This evidence concerns the gene NFE2L2 and diabetic kidney disease.